Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:09 PM
Ignite Modification Date:
2025-12-24 @ 10:09 PM
NCT ID:
NCT03558035
Eligibility Criteria:
Inclusion Criteria:
* Histologically proven squamous cell carcinoma of hypopharynx
* Stage III/IV M0, with T3/4 N0-3 or T1-4 N2-3
* Karnofsky Performance Status\>=70
* Have measurable lesions on CT/MRI
* Treatment for the first time
* Expected lifetime \> 6 months
* Normal blood test, hepatic and renal functions
* Normal hearing
* Can understand and sign the consent
* Have follow up condition
Exclusion Criteria:
* Past malignancies history (except for stage I non-melanoma skin cancer or cervical carcinoma in situ)
* Previously treatment for cancer
* Pregnant or breeding woman, female without contraception
* Enrolling in other drug trials
* Severe comorbidities including myocardial infarction, arrhythmia, cerebral vascular disease, ulceration disease, mental disease and uncontrolled diabetes
* Without follow up
* Receive target therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT03558035
Study Brief:
Protocol Section:
NCT03558035